The aim is to identify potential superbug outbreaks before they become a threat, and therefore prevent infections – enhancing protection for Victoria’s most vulnerable patients. Rapid genomic sequencing of superbugs means that results can be reported in a matter of days, enabling real-time action on reducing infection risk.
Patients at particular risk from superbugs include those in intensive-care units, those being treated for cancers or particular blood disorders, and transplant recipients.
Click here for information on Melbourne Genomics' controlling superbugs project.